Sen. Markwayne Mullin Buys Elevance Health, Inc. (NYSE:ELV) Stock

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of Elevance Health, Inc. (NYSE:ELV). In a filing disclosed on January 16th, the Senator disclosed that they had bought between $15,001 and $50,000 in Elevance Health stock on December 29th.

Senator Markwayne Mullin also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Deere & Company (NYSE:DE) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Hilton Worldwide (NYSE:HLT) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of CocaCola (NYSE:KO) on 12/29/2025.
• Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 12/29/2025.
• Purchased $100,001 – $250,000 in shares of Amazon.com (NASDAQ:AMZN) on 12/29/2025.
• Purchased $50,001 – $100,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Boston Scientific (NYSE:BSX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 12/29/2025.

Elevance Health Stock Performance

Shares of ELV stock traded down $7.07 during trading on Friday, reaching $374.86. 1,074,663 shares of the company’s stock traded hands, compared to its average volume of 1,146,480. The firm’s 50-day moving average is $344.10 and its 200 day moving average is $328.03. The company has a market capitalization of $83.31 billion, a P/E ratio of 15.33, a PEG ratio of 1.93 and a beta of 0.51. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.71.

Elevance Health (NYSE:ELV) last issued its earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.03 by $1.00. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The business had revenue of $50.09 billion for the quarter, compared to analysts’ expectations of $49.26 billion. During the same quarter in the previous year, the firm posted $8.37 EPS. The business’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Weiss Ratings raised Elevance Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. TD Cowen boosted their price objective on shares of Elevance Health from $380.00 to $400.00 and gave the company a “buy” rating in a research note on Wednesday, November 26th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $431.00 target price on shares of Elevance Health in a research note on Tuesday, January 6th. Robert W. Baird boosted their price target on shares of Elevance Health from $297.00 to $340.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Finally, Wolfe Research set a $425.00 price objective on Elevance Health and gave the stock an “outperform” rating in a research report on Thursday, January 8th. Thirteen equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $400.85.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Aaron Wealth Advisors LLC boosted its holdings in shares of Elevance Health by 66.5% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 1,087 shares of the company’s stock worth $423,000 after purchasing an additional 434 shares in the last quarter. Goelzer Investment Management Inc. grew its holdings in shares of Elevance Health by 61.7% during the 2nd quarter. Goelzer Investment Management Inc. now owns 1,332 shares of the company’s stock valued at $518,000 after purchasing an additional 508 shares during the last quarter. Chesley Taft & Associates LLC raised its position in Elevance Health by 3.1% in the 2nd quarter. Chesley Taft & Associates LLC now owns 3,804 shares of the company’s stock worth $1,480,000 after purchasing an additional 115 shares during the period. Pines Wealth Management LLC raised its position in Elevance Health by 29.5% in the 2nd quarter. Pines Wealth Management LLC now owns 694 shares of the company’s stock worth $270,000 after purchasing an additional 158 shares during the period. Finally, Dynamic Advisor Solutions LLC lifted its stake in Elevance Health by 11.3% in the second quarter. Dynamic Advisor Solutions LLC now owns 8,034 shares of the company’s stock worth $3,125,000 after purchasing an additional 817 shares during the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.